First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLL.
| Image |  |
|---|---|
| Description | scientific article published on 22 January 2018 |
| Author/s |
author: John C. Byrd Ranjana H. Advani |
| Publication date | January 22, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |